SiegelRLMillerKDJemalA.Cancer statistics, 2019. CA Cancer J Clin2019;
69: 7–34.
2.
HaoY-BYiS-YRuanJ, et al.
New insights into metronomic chemotherapy-induced immunoregulation. Cancer Lett2014;
354: 220–226.
3.
OunRMoussaYEWheateNJ.The side effects of platinum-based chemotherapy drugs: a review for chemists. Dalton Trans2018;
47: 6645–6653.
4.
QinS-YZhangA-QChengS-X, et al.
Drug self-delivery systems for cancer therapy. Biomaterials2017;
112: 234–247.
5.
LiRXieY.Nanodrug delivery systems for targeting the endogenous tumor microenvironment and simultaneously overcoming multidrug resistance properties. J Control Release2017;
251: 49–67.
6.
JahangirianHLemraskiEGWebsterTJ, et al.
A review of drug delivery systems based on nanotechnology and green chemistry: green nanomedicine. Int J Nanomed2017;
12: 2957.
7.
KoushikORaoYKumarP, et al.
Nano drug delivery systems to overcome cancer drug resistance – a review. J Nanomed Nanotechnol2016;
7: 2.
8.
SunHSuJMengQ, et al.
Cancer cell membrane-coated gold nanocages with hyperthermia-triggered drug release and homotypic target inhibit growth and metastasis of breast cancer. Adv Funct Mater2017;
27: 1604300.
9.
SuJSunHMengQ, et al.
Bioinspired nanoparticles with NIR-controlled drug release for synergetic chemophotothermal therapy of metastatic breast cancer. Adv Funct Mater2016;
26: 7495–7506.
10.
WuFZhangMLuH, et al.
Triple stimuli-responsive magnetic hollow porous carbon-based nanodrug delivery system for magnetic resonance imaging-guided synergistic photothermal/chemotherapy of cancer. ACS Appl Mater Interf2018;
10: 21939–21949.
11.
LiuYWangWYangJ, et al.
pH-sensitive polymeric micelles triggered drug release for extracellular and intracellular drug targeting delivery. Asian J Pharm Sci2013;
8: 159–167.
12.
ZhouMWenKBiY, et al.
The application of stimuli-responsive nanocarriers for targeted drug delivery. Curr Top Med Chem2017;
17: 2319–2334.
13.
LeeESOhKTKimD, et al.
Tumor pH-responsive flower-like micelles of poly (l-lactic acid)-b-poly (ethylene glycol)-b-poly (l-histidine). J Control Release2007;
123: 19–26.
14.
BalendiranGKDaburRFraserD.The role of glutathione in cancer. Cell Biochem Funct2004;
22: 343–352.
15.
XuZLiuSKangY, et al.
Glutathione-and pH-responsive nonporous silica prodrug nanoparticles for controlled release and cancer therapy. Nanoscale2015;
7: 5859–5868.
16.
LiYZhiXLinJ, et al.
Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release. Mater Sci Eng C Mater Biol Appl2017;
73: 189–197.
17.
ThakurVSGuptaKGuptaS.Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases. Carcinogenesis2011;
33: 377–384.
18.
León-GonzálezAJAugerCSchini-KerthVB.Pro-oxidant activity of polyphenols and its implication on cancer chemoprevention and chemotherapy. Biochem Pharmacol2015;
98: 371–380.
19.
CarlsonJRBauerBAVincentA, et al.
Reading the tea leaves: anticarcinogenic properties of (–)-epigallocatechin-3-gallate. Mayo Clin Proc2007;
82: 725–732.
20.
ChenZWangCChenJ, et al.
Biocompatible, functional spheres based on oxidative coupling assembly of green tea polyphenols. J Am Chem Soc2013;
135: 4179–4182.
21.
LiJWuSWuC, et al.
Versatile surface engineering of porous nanomaterials with bioinspired polyphenol coatings for targeted and controlled drug delivery. Nanoscale2016;
8: 8600–8606.
22.
MahboubehRJaberEAbolfazlM, et al.
A rapid and sensitive HPLC method for quantitation of paclitaxel in biological samples using liquid-liquid extraction and UV detection: application to pharmacokinetics and tissues distribution study of paclitaxel loaded targeted polymeric micelles in tumor bearing mice. J Pharm Pharm Sci2015;
18: 647–660.
23.
MiyataRAndoNUedaM, et al.
Selective targeting to liver and increased chemosensitivity to hepatocellular carcinoma by HBsAg conjugated MPC polymer as a biocompatible carrier for paclitaxel. Int J Cancer2008;
68: 5603–5603.
24.
ZhangHYiZSunZ, et al.
Functional nanoparticles of tea polyphenols for doxorubicin delivery in cancer treatment. J Mater Chem B2017;
5: 7622–7631.
25.
ChengTLiuJJieR, et al.
Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics2016;
6: 1277–1292.
26.
YiSWangYHuangY, et al.
Tea nanoparticles for immunostimulation and chemo-drug delivery in cancer treatment. J Biomed Nanotechnol2014;
10: 1016–1029.
27.
ChenLZangFWuH, et al.
Using PEGylated magnetic nanoparticles to describe the EPR effect in tumor for predicting therapeutic efficacy of micelle drugs. Nanoscale2018;
10: 1788–1797.
28.
LakenbrinkCEngelhardtUHWrayV.Identification of two novel proanthocyanidins in green tea. J Agric Food Chem1999;
47: 4621–4624.
29.
JiangH-yShiiTMatsuoY, et al.
A new catechin oxidation product and polymeric polyphenols of post-fermented tea. Food Chem2011;
129: 830–836.
